Results 331 to 340 of about 288,185 (387)

Effectiveness of GLP‐1RA according to different type 2 diabetes phenotypes: A retrospective study

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Type 2 diabetes (T2D) is a heterogeneous disease, with varying pathogenetic mechanisms influencing treatment response. Glucagon‐like peptide‐1 receptor agonists (GLP‐1RA) offer clear metabolic benefits in T2D, but interindividual variability in response is observed.
Irene Caruso   +9 more
wiley   +1 more source

An Unusual Case of Membranoproliferative Glomerulonephritis: Is the Role of Vaccination in Immune Reactivation a Casual or Causal Effect? [PDF]

open access: yesReports (MDPI)
Rodríguez Tudero C   +4 more
europepmc   +1 more source

How does LAMB2 contribute to kidney disease? Insights from a pediatric case. [PDF]

open access: yesBMC Nephrol
Trutin I   +4 more
europepmc   +1 more source

Calcinosis cutis of the lower legs – hyperphosphatemic familial tumoral calcinosis in a patient with GALNT3 mutation

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
David Ranzinger   +4 more
wiley   +1 more source

PLA2R1 and HLA-DQA1 SNP in patients with primary membranous nephropathy. [PDF]

open access: yesPLoS One
Zhou J   +12 more
europepmc   +1 more source

Type I IFN receptor blockade by anifrolumab reduces cutaneous lupus in monogenic SLE

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Julian Steininger   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy